The European Commission (EC) has granted approval for Takeda's antibody-drug conjugate (ADC) Adcetris (brentuximab vedotin).

Modern drug development approaches that integrate functional plans with larger business goals are needed for success in early ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix", "the Company") today announces that its prostate cancer PET[1] ...

The healthcare tech firm's stock fell as much as 4.68 per cent during the day to ₹590 per share, the biggest intraday loss ...

TAIPEI (Taiwan News) — Taiwan won 18 accolades in Florida at this year's Edison Awards, an annual event recognizing ...

Glenn Sykes, a lifelong resident of the Philadelphia area, is hosting a special night at Theatre Exile for the show “Glitter ...

Wockhardt Ltd. expects to regain its revenue levels of around Rs 5,000 crore, last seen in 2014–15, within the next three ...

THE DA SAYS THE 45 YEAR OLD REFUSED TO GET THIS DOG VETERINARY CARE FOR DAYS. A QUARRYVILLE AREA VET CONTACTED POLICE IN MAY STATING THAT STOLTZFOOS HAD BEEN ASKING FOR PAIN MEDICATION FOR THE DOG, ...

Regencell's stock soared 17,000% fueled by speculation, despite no revenue or clinical progress. Read why I think the RGC ...

In the first part of this series, we explored how early genetic screening and gene therapy transform the lives of newborns ...

June 3, 2025) - This National Cancer Survivor Month, St. Baldrick's Foundation, the largest charity funder of childhood cancer research grants in the U.S., is proud to launch its June campaign, "Their ...

Shares in MaaT Pharma (Euronext: MAAT), a French microbiome company in oncology, closed 25% higher Tuesday. The company ...